Mitsumoto, H., Brooks, B. R., and Silani, V. (2014). Clinical trials in amyotrophic lateral sclerosis: Why so many negative trials and how can trials be improved?
Moher, D., Schulz, K. F., and Altman, D. G. (2001). The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials.
Morris, M. W. and Peng, K. (1994). Culture and Cause: American and Chinese Attributions for Social and Physical Events.
Mosca, L., Manson, J. E., Sutherland, S. E., Langer, R. D., Manolio, T., and Barrett-Connor, E. (1997). Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. Writing Group.
Mostofsky, E., Rice, M. S., Levitan, E. B., and Mittleman, M. A. (2012). Habitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis.
Mott, N. L. (2003). The Current Debate on Juror Questions: To Ask or Not to Ask, That Is the Question.
Muntner, P., Safford, M. M., Cushman, M., and Howard, G. (2014). Comment on the Reports of Over-estimation of ASCVD Risk Using the 2013 AHA/ACC Risk Equation.
Murphy, K. (2002).
Nadelhoffer, T. (2004). On Praise, Side Effects, and Folk Ascriptions of Intentionality.
Narayanan, A. and Shmatikov, V. (2008). Robust Deanonymization of Large Sparse Datasets. In